Search Results 241-250 of 15708 for pharmacogenetics
See educational opportunities and alumni in Nilufer Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes lab at Mayo Clinic.
The eMERGE Genome Informed Risk Assessment study at Mayo Clinic estimates adult participants' risk of getting certain conditions from rare variants in a ...
About this study. The objectives of this protocol are to develop and validate clinical assays for inborn errors of metabolism (IEMs) using specimens ...
This medicine is to be given only by or under the supervision of your doctor or other health care professional. This product is available in the following ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of ...
Efbemalenograstim alfa-vuxw injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. The primary objective of the study is to utilize comprehensive, family-centered genomic screening strategies - chromosomal microarray ...
Learn about high-quality healthcare services for practicing physicians, including customized visits, efficient assessments and job fitness evaluations.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.